Brief: Mineralys Therapeutics Announces Repurchase Of Royalty Obligations In Tanabe License Agreement And Concurrent Financing
03/06/2026 11:26
BRIEF-Mineralys Therapeutics Announces Repurchase Of Royalty Obligations In Tanabe License Agreement And Concurrent Financing June 3 (Reuters) - Mineralys Therapeutics Inc MLYS.O:
MINERALYS THERAPEUTICS ANNOUNCES REPURCHASE OF ROYALTY OBLIGATIONS IN TANABE LICENSE AGREEMENT AND CONCURRENT FINANCING
MINERALYS THERAPEUTICS - TO REPURCHASE LORUNDROSTAT ROYALTY OBLIGATION FOR $200 MILLION UPFRONT, UP TO $100 MILLION IN MILESTONES
MINERALYS THERAPEUTICS - SECURES $500 MILLION SENIOR SECURED TERM LOAN FACILITY FROM PHARMAKON ADVISORS
MINERALYS THERAPEUTICS - PRICES $150 MILLION COMMON STOCK OFFERING
Source text: ID:nGNX9t1NND
Further company coverage: MLYS.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway